Sentynl Therapeutics Inc (Sentynl), a US-based biopharmaceutical organization entirely claimed by Ahmedabad-settled Zydus Lifesciences, as of late finished the procurement of worldwide exclusive rights for Zokinvy. Zokinvy is the first and only...
Context Therapeutics Inc, a biopharmaceutical firm creating therapies for solid tumors based in Philadelphia, reported that the US FDA has approved its Investigational New Drug application for CTIM-76, a bispecific antibody that targets Claudin 6...
Cocrystal Pharma, Inc. reports that the randomized, double-blind, placebo-controlled phase 2a human challenge clinical study assessing the safety, tolerability, antiviral, and clinical measurements of its novel, oral PB2 inhibitor CC-42344, which...
Abbott, the global healthcare company,announced the launch of XIENCE Sierra Everolimus (drug) Eluting Coronary Stent System in India. XIENCE Sierra is one of the latest generation stents in the XIENCEâ„¢ family, now available to people suffering...
The 4th Annual Pharma GMP & Quality Management 2024, held at NOVOTEL Mumbai International Airport on April 25th and 26th, emerged as a pivotal event in the pharmaceutical industry landscape, fostering collaboration, innovation, andexcellence.
Boehringer Ingelheim Group, which is one of the world's largest manufacturers of biologic medicines, has declared that the US Food and Drug Administration (FDA) has approved its high-concentration, citrate-free formulation of Cyltezo (adalimumab...
In the glistening ambiance of success and camaraderie, the stage was set for an evening of unparalleled splendor and distinction as the maiden edition of Pharma Quality Excellence Awards 2024 unfolded in all its grandeur.
Novartis, a leading innovative medicines company, has announced its intention to acquire Mariana Oncology, a US-based biotechnology firm that specializes in the development of novel radioligand therapies (RLTs) to treat cancers with a high unmet...
ClearPoint Neuro, a global therapy-enabling platform, and quality treatment empowering organization offering exact route to the brain and spine, declared it has secured 510(k) approval for its Prism Bone Anchor Accessory. The company's second new...
Pfizer Inc, a pharmaceutical industry firm and Genmab A/S reported that the US Food and Drug Administration (FDA) endorses the supplemental Biologics License Application (sBLA) giving full endorsement for Tivdak (tisotumab vedotin-tftv) for the...
, CDSCO.jpg)
.jpg)